We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

131 hedge funds and large institutions have $528M invested in Voyager Therapeutics in 2019 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 27 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,200% more call options, than puts

Call options by funds: $1.67M | Put options by funds: $18K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

89% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 27

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

5% more funds holding

Funds holding: 125 → 131 (+6)

3.54% more ownership

Funds ownership: 79.52% → 83.06% (+3.5%)

34% less capital invested

Capital invested by funds: $796M → $528M (-$268M)

Holders
131
Holders Change
+6
Holders Change %
+4.8%
% of All Funds
2.87%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
28
Increased
51
Reduced
27
Closed
22
Calls
$1.67M
Puts
$18K
Net Calls
+$1.66M
Net Calls Change
-$4.71M

Top Buyers

Rank Fund Capital Flow
1
ClearBridge Investments
ClearBridge Investments
New York
+$18.1M
2
BC
Boxer Capital
California
+$8.4M
3
Renaissance Technologies
Renaissance Technologies
New York
+$7.2M
4
FCMI
Foresite Capital Management IV
California
+$6.17M
5
N
Nuveen
North Carolina
+$5.55M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$20.4M
2
PHS
PFM Health Sciences
California
-$18.6M
3
Millennium Management
Millennium Management
New York
-$13.3M
4
HCM
Highline Capital Management
New York
-$8.08M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$3.43M -$2.67M -127,184 -39%
Charles Schwab
27
Charles Schwab
California
$3.43M +$1.25M +59,372 +42%
RJFSA
28
Raymond James Financial Services Advisors
Florida
$3.38M -$238K -11,346 -5%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$3.02M -$1.85M -88,076 -33%
American Century Companies
30
American Century Companies
Missouri
$2.69M +$527K +25,103 +19%
FT
31
Fiduciary Trust
Massachusetts
$2.67M – – –
Squarepoint
32
Squarepoint
New York
$2.53M +$3.08M +146,770 New
3C
33
361 Capital
Colorado
$2.07M +$2.52M +120,143 New
B
34
Bailard
California
$2.02M +$1.61M +76,500 +187%
HAM
35
HHR Asset Management
New Jersey
$1.96M – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.72M +$4.33K +206 +0.2%
UBS Group
37
UBS Group
Switzerland
$1.66M +$1.54M +73,173 +311%
PPA
38
Parametric Portfolio Associates
Washington
$1.66M +$2.02M +96,190 New
Rafferty Asset Management
39
Rafferty Asset Management
New York
$1.59M +$618K +29,422 +47%
Bank of America
40
Bank of America
North Carolina
$1.54M +$526K +25,049 +39%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$1.46M -$351K -16,700 -16%
AQR Capital Management
42
AQR Capital Management
Connecticut
$1.34M +$1.2M +57,299 +278%
Two Sigma Investments
43
Two Sigma Investments
New York
$1.31M +$595K +28,339 +60%
Citigroup
44
Citigroup
New York
$1.27M -$175K -8,341 -10%
AA
45
ALPS Advisors
Colorado
$1.27M -$71.5K -3,408 -4%
QI
46
QS Investors
New York
$1.24M +$2.1K +100 +0.1%
Man Group
47
Man Group
United Kingdom
$1.15M +$1.4M +66,800 New
ARTA
48
A.R.T. Advisors
New York
$1.1M +$773K +36,800 +136%
Swiss National Bank
49
Swiss National Bank
Switzerland
$891K +$132K +6,300 +14%
CSS
50
Cubist Systematic Strategies
Connecticut
$884K +$1.08M +51,370 New
1
2
3 4 5

VYGR Hedge Fund Activity: Q3 2019 in Review

131 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q3 2019, worth a combined $528M — down 34% from $796M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new VYGR positions and 22 closed out — a net gain of 6 holders — while 51 added to existing stakes and 27 trimmed.

The largest buyer was ClearBridge Investments, adding an estimated $18.1M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $20.4M sold.

  • 131 institutional investors held Voyager Therapeutics (VYGR) as of Q3 2019, up from 125 in Q2 2019.
  • Funds reported $528M of Voyager Therapeutics stock for Q3 2019, down 34% quarter-over-quarter.
  • 28 funds opened new Voyager Therapeutics positions in Q3 2019 and 22 closed out, a net change of +6 holders.
  • The largest Voyager Therapeutics buyer in Q3 2019 was ClearBridge Investments, an estimated $18.1M added.
  • The largest Voyager Therapeutics seller in Q3 2019 was Farallon Capital Management, an estimated $20.4M sold.

Based on aggregated 13F filings for Q3 2019.